{HEAD ~ The therapeutic compositions} can be and formulated to reduce the extent of a Plasmodium infection in the recipient subject, or to reduce {TAIL ~ the likelihood} of the onset or establishment of a Plasmodium infection if administered prior to the parasite contacting the subject 
formulated to reduce
{ HEAD ~ The therapeutic compositions } can be and formulated to reduce the extent of a Plasmodium infection in the recipient subject , or to reduce { TAIL ~ the likelihood } of the onset or establishment of a Plasmodium infection if administered prior to the parasite contacting the subject
HEAD HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH REL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH REL REL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH